[Iron Metabolism and Iron Therapy in Chronic Renal Failure].

Iron therapy in nephropathic patients can allow optimizing treatment with EPO identifying the minimum effective dose capable of improving the patient's quality of life. The most recent studies on iron metabolism and on the interference of iron deficiency syndrome on the performance of some organs, in particular the myocardium, suggest the need to intervene very early, especially in patients with cardiomyopathy and systolic deficit. Setting up an iron therapy in nephropathic patients requires a correct diagnosis.

Diffusion and thermodynamic properties of lithium polysulfides in different solvents: a molecular dynamics approach.

Li-S batteries are promising alternatives due to their proven increased gravimetric capacity compared to Li-ion batteries. However, their development is hindered by many technical issues, one of the most challenging being the dissolution and shuttle of polysulfide species, which causes irreversible loss of cathode material leading to rapid capacity fading. Among the possible strategies to mitigate this effect, the choice of suitable solvents is easy to implement and has large room for improvement.

Sepiolite as a novel polysulfide trapper for energy applications: an electrochemical, X-ray spectroscopic and DFT study.

Capacity retention is a critical property to enhance in electrochemical storage systems applied to renewable energy. In lithium-sulfur (Li-S) batteries, the capacity fade resulting from the shuttle effect of polysulfides is a major obstacle to their practical application. Sepiolite, an eco-friendly earth-abundant clay with suitable surface chemistry for anchoring and retaining various molecules and structures, was studied as a cathode additive to mitigate the shuttle effect using experimental and theoretical approaches.

Galvanostatic Fast Charging of Alkali-Ion Battery Materials at the Single-Particle Level: A Map-Driven Diagnosis.

In this work, we develop a new tool to provide a diagnostic map for alkali-ion intercalation materials under galvanostatic conditions. These representations, stated in the form of capacity level diagrams, are built from hundreds of numerical simulations representing different experimental conditions, summarized in two dimensionless parameters: a kinetic parameter denominated Ξ and a finite diffusion parameter l. To lay the theoretical and methodological foundations, a general model is used here.

Voltammetric Behaviour of LMO at the Nanoscale: A Map of Reversibility and Diffusional Limitations.

Understanding and optimizing single particle rate behaviour is normally challenging in composite commercial lithium-ion electrode materials. In this regard, recent experimental research has addressed the electrochemical Li-ion intercalation in individual nanosized particles. Here, we present a thorough theoretical analysis of the Li intercalation voltammetric behaviour in single nano/micro-scale LiMn O (LMO) particles, incorporating realistic interactions between inserted ions.

Characterization of amorphous LiSi structures from ReaxFF accelerated exploration of local minima.

Motivated by the abundant experimental work in the area of Li-ion batteries, in the present work we characterize via computer simulations the structure of Si-Li amorphous alloys in a wide range of compositions. Using a reactive force field we propose a novel accelerated exploration of local minima to obtain amorphous structures close to equilibrium. The features of this system analyzed for different alloy compositions are the partial radial distribution functions g(r), the first and second nearest neighbour coordination numbers and the short-order structure.

Unveiling the stability of Sn/Si/graphite composites for Li-ion storage by physical, electrochemical and computational tools.

Complex materials composed of two and three elements with high Li-ion storage capacity are investigated and tested as lithium-ion battery (LiB) negative electrodes. Namely, anodes containing tin, silicon, and graphite show very good performance because of the large gravimetric and volumetric capacity of silicon and structural support provided by tin and graphite. The performance of the composites during the first cycles was studied using ex situ magic angle spinning (MAS) Li Nuclear Magnetic Resonance (NMR), density functional theory (DFT) calculations, and electrochemical techniques.

Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients.

We present real-world data on all ruxolitinib-treated myelofibrosis patients in a 10-million-resident region, with a follow-up of 2 years. We found no evidence of an increased risk of developing lymphomas.

Standard care and investigational drugs in the treatment of myelofibrosis.

Myelofibrosis (MF) is a heterogeneous disorder characterized by splenomegaly, constitutional symptoms, ineffective hematopoiesis, and an increased risk of leukemic transformation. The ongoing research in understanding the pathophysiology of the disease has allowed for the development of targeted drugs optimizing patient management. Furthermore, disease prognostication has significantly improved.

Assessment of FLUKA, PENELOPE and MCNP6 Monte Carlo codes for estimating gold fluorescence applied to the detection of gold-infused tumoral volumes.

Different kinds of nanoparticles have been widely studied for biomedical purposes, including applications like dose enhancement in radiotherapy treatments and contrast agent in radiological studies. Recent work suggests that gold nanoparticles can be used as contrast agents in K-edge imaging and X-ray Fluorescence Computed Tomography, mainly due to their high K-edge energy value and good biocompatibility. However, the gold X-ray fluorescence (XRF) signal obtained in these procedures is relatively week when compared with Compton or bremsstrahlung radiation emitted in the surrounding tissues, mainly because it is not possible to achieve large gold nanoparticles concentrations within biological tissues added to the XRF is attenuated by other tissues when leaving the patient body.

Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.

Patients with myeloproliferative neoplasms (MPN) are known to have higher incidence of nonhematological second primary malignancies (SPM) compared to general population. In the MYSEC study on 781 secondary myelofibrosis (SMF) patients, the incidence of SPM after SMF diagnosis resulted 0.98/100 patient-years.

Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis.

Purpose Of Review: The purpose of this review is to help doctors in the management of patients with post-polycythemia (PPV) and post-essential thrombocythemia (PET) myelofibrosis (MF) facing diagnostic criteria, prognostication, and treatment possibilities.

Recent Findings: Diagnostic criteria of primary myelofibrosis (PMF) have been recently updated from the WHO classification. A clear-cut distinction between pre-fibrotic and overt PMF has been done.

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.

In a recent International Working Group on Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) study, prior arterial events and hypertension were predictors of subsequent arterial thrombosis whereas prior venous events and age ≥65 years predicted venous thrombosis in polycythemia vera (PV). In the current study, we sought to validate the above findings and identify additional predictors of arterial versus venous thrombosis. At a median follow up of 109 months, thrombosis after diagnosis occurred in 128 (22%) patients; 82 (14%) arterial and 57 (10%) venous events.